Group One Trading’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100
Closed -$67 8654
2023
Q2
$67 Buy
+100
New +$88 ﹤0.01% 7531
2023
Q1
Sell
-100
Closed -$126 8219
2022
Q4
$126 Buy
+100
New +$228 ﹤0.01% 7063
2022
Q3
Sell
-675
Closed -$4K 8510
2022
Q2
$4K Sell
675
-1,860
-73% -$17.5K ﹤0.01% 7250
2022
Q1
$30K Sell
2,535
-10,760
-81% -$147K ﹤0.01% 6490
2021
Q4
$260K Sell
13,295
-1,420
-10% -$31.8K ﹤0.01% 4809
2021
Q3
$383K Buy
14,715
+11,710
+390% +$276K ﹤0.01% 4488
2021
Q2
$66K Buy
+3,005
New +$73.8K ﹤0.01% 6343
2021
Q1
Sell
-165
Closed -$3K 8179
2020
Q4
$3K Buy
+165
New +$2.75K ﹤0.01% 6200
2020
Q2
Sell
-750
Closed -$8K 6335
2020
Q1
$8K Hold
750
﹤0.01% 4653
2019
Q4
$8K Buy
+750
New +$12.5K ﹤0.01% 4669
2019
Q2
Sell
-15
Closed -$1K 5536
2019
Q1
$1K Sell
15
-295
-95% -$12.8K ﹤0.01% 4685
2018
Q4
$14K Sell
310
-945
-75% -$70K ﹤0.01% 4166
2018
Q3
$171K Buy
1,255
+675
+116% +$116K ﹤0.01% 3122
2018
Q2
$273K Buy
+580
New +$213K ﹤0.01% 2792

Other funds holding NMTR

Group One Trading's NMTR Position: Q3 2023 in Review

Group One Trading sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 10,363 shares — an estimated $6.96K sold.

Group One Trading first reported a position in NMTR in Q3 2018 and held it in 15 quarters. The position peaked at $618K in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Group One Trading reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 10,363 9 Meters Biopharma shares in Q3 2023, an estimated $6.96K.
  • Group One Trading first reported a position in 9 Meters Biopharma in Q3 2018 and held it in 15 quarters.
  • Group One Trading's 9 Meters Biopharma position peaked at $618K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.